NMRA vs ROST · $283.5M cap vs P/E 21, rev $21.13B
Neumora Therapeutics, Inc. (NMRA) versus Ross Stores Inc (ROST) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Ross Stores Inc (ROST) is a apparel retail company listed on US.
NMRA does not have a complete income-statement cache yet.
Latest reported ROST revenue for 2025-02-01 was $21.13B. Net income was $2.09B. Revenue was up 3.7% from 2024-02-03 to 2025-02-01. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
NMRA currently screens at market cap $283.5M. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
Not investment advice. Open the NMRA and ROST stock pages for the full models.
Not investment advice.